Director of the Lieber Institute for Brain Development and Professor, Departments of Psychiatry, Neurology, Neuroscience and The Institute of Genetic Medicine, Johns Hopkins University.
Daniel R. Weinberger
Professor
Johns Hopkins University
From this contributor
Pitt-Hopkins syndrome may point the way to autism treatments
Researchers have identified a drug that works in individual cells and rodent models of a form of autism known as Pitt-Hopkins syndrome.
Pitt-Hopkins syndrome may point the way to autism treatments
By
Daniel R. Weinberger, The Conversation
1 May 2019 | 6 min read
Explore more from The Transmitter
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
By
Charles Q. Choi
20 November 2025 | 5 min read
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
By
Paul Middlebrooks
19 November 2025 | 1 min read
Role of maternal factors in autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 17 November.
Role of maternal factors in autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 17 November.
By
Jill Adams
18 November 2025 | 2 min read